EUCTR2014-005140-18-IT进行中（未招募）1 期
Diagnostic and clinical value of fused 64CuCl2-PET/MRI in prostate cancer relapse. Comparison with multiparametric MRI (mMRI) and 18F-Choline-PET/MRI - Diagnostic and clinical value of 64CuCl2-PET/MRI in prostate cancer relapse.
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •-years > 18 (no upper age limit)
- •-all histologically proven prostate cancer patients who showed biochemical relapse after surgery or first-line treatment with radiotherapy
- •-Gleason score =6,
- •-increasing levels of PSA and PSA doubling time (DT) =6 months.
- •-Informed consent available
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 1
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 15
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 35
排除标准
- •-comorbidity for other neoplasms
- •-inability to perform MRI
- •-known hypersensitivity to the substances or excipients contained in the tracers and contrast agent
研究者
相似试验
进行中（未招募）
1 期
Diagnostic-predictive value of copper-64 dichloride in bladder cancer patients eligible for chemotherapybladder cancer patients eligible for cisplatin chemotherapyMedDRA version: 20.0Level: SOCClassification code 10029104Term: Neoplasms benign, malignant and unspecified (incl cysts and polyps)System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2019-002534-37-ITENTE OSPEDALIERO OSPEDALI GALLIERA50
进行中（未招募）
1 期
se of the diagnostic PET with 64CuCl2 in order to select patients, in which a disease relapse is shown after prostate surgical removal, to be successfully treated to radiation therapy on the prostate bedcancer on the prostatic bedMedDRA version: 20.0Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-004332-11-ITSPARKLE SR138
进行中（未招募）
1 期
better diagnostic accuracy and ability to detect multiple metastases of the PET exam with a new experimental radiopharmaceutical (64CuCl2) in the diagnosis of metastases in patients with prostate cancer compared to the PET / CT examination performed with 18F-choline.EUCTR2019-000744-10-ITSPARKLE SR111
招募中
不适用
tility study of PET imaging with 64Cu-DOTA labeled antibody probes against HER2 and EGFRBreast cancer, Gastric cancer, Colorectal cancer, GliomaJPRN-UMIN000017446ational Cancer Center Hospital200
进行中（未招募）
1 期
Combined 64Cu-DOTATATE and 18F-FDG PET/CT Imaging in Patients with Neuroendocrine Tumorseuroendocrine neoplasmsMedDRA version: 21.0Level: LLTClassification code 10062476Term: Neuroendocrine tumorSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10057270Term: Neuroendocrine carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: LLTClassification code 10068916Term: Pancreatic neuroendocrine tumor metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10071542Term: Neuroendocrine carcinoma metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10077560Term: Gastroenteropancreatic neuroendocrine tumor diseaseSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: LLTClassification code 10067518Term: Pancreatic neuroendocrine tumorSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 24.1Level: LLTClassification code 10085846Term: Duodenal neuroendocrine tumorSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 24.1Level: LLTClassification code 10085958Term: Small intestine neuroendocrine tumorSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2021-005919-30-DKDepartment of Clinical Physiology and Nuclear Medicine, Rigshospitalet200